Literature DB >> 36247288

Serum microRNAs as non-invasive diagnostic biomarkers for intrahepatic cholestasis of pregnancy.

Yue Zu1, Sheng Guo2, Guodong Li1, Qianyan Gao1, Ximin Wang1, Chengliang Zhang1, Dong Liu1.   

Abstract

OBJECTIVES: Intrahepatic cholestasis of pregnancy (IHCP) causes itching, preterm birth, and stillbirth. However, there is no accurate diagnostic method for IHCP. Currently, circulating microRNAs (miRNAs) have become candidate biomarkers for the diagnosis of multiple diseases. Here, we investigated the diagnostic value of miRNAs in IHCP and aimed to predict the molecular mechanism of IHCP pathogenesis.
METHODS: We analyzed differentially expressed miRNAs in both women with IHCP and normal pregnant women. The selected candidate miRNAs were validated in 46 IHCP cases and 46 normal pregnant subjects, and we constructed receiver operator characteristic curves of miRNAs. Pearson correlations between levels of total bile acid (TBA) and differentially expressed miRNAs were also calculated. In addition, we clustered functionally significant biological pathways using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses.
RESULTS: The expression levels of 13 miRNAs were remarkably upregulated while the other 35 miRNAs were significantly downregulated, in women with IHCP (P≤0.05) when compared with healthy pregnant women. The areas under the curves of miRNA-7706, miRNA-877-3p, and miRNA-128-3p were higher than 0.90, indicating more reliable diagnosis of IHCP. The Pearson analysis showed that the levels of these miRNAs were positively correlated to TBA level. Additionally, the results of bioinformatics analysis revealed that the differentially expressed miRNAs mainly influenced fatty acid biosynthesis, the endoplasmic reticulum ubiquitin ligase complex, and the p53, and mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) signaling pathways.
CONCLUSION: The panel of three-miRNAs (miRNA-7706, miRNA-877-3p, and miRNA-128-3p) may be a useful noninvasive diagnostic biomarker of IHCP. AJTR
Copyright © 2022.

Entities:  

Keywords:  bioinformatics analysis; diagnostic biomarkers; intrahepatic cholestasis of pregnancy; miRNAs; microarray analysis

Year:  2022        PMID: 36247288      PMCID: PMC9556493     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  50 in total

1.  MicroRNA expression profile of bromocriptine-resistant prolactinomas.

Authors:  Zhe Bao Wu; Wei Qiang Li; Shao Jian Lin; Cheng De Wang; Lin Cai; Jiang Long Lu; Yun Xiang Chen; Zhi Peng Su; Han Bing Shang; Wen Lei Yang; Wei Guo Zhao
Journal:  Mol Cell Endocrinol       Date:  2014-07-23       Impact factor: 4.102

2.  Bioinformatics‑based identification of key pathways and candidate genes for estrogen‑induced intrahepatic cholestasis using DNA microarray analysis.

Authors:  Dong Xiang; Yanjiao Xu; Wenxi He; Jinyu Yang; Chengliang Zhang; Dong Liu
Journal:  Mol Med Rep       Date:  2019-05-16       Impact factor: 2.952

3.  UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.

Authors:  Xiaojiaoyang Li; Zihang Yuan; Runping Liu; Hozeifa M Hassan; Hang Yang; Rong Sun; Luyong Zhang; Zhenzhou Jiang
Journal:  Toxicol Appl Pharmacol       Date:  2016-10-12       Impact factor: 4.219

4.  MicroRNAs derived from urinary exosomes act as novel biomarkers in the diagnosis of intrahepatic cholestasis of pregnancy.

Authors:  Pei-Yue Jiang; Xiao-Jun Zhu; Ruo-An Jiang; Yi-Na Zhang; Liu Liu; Xiao-Fu Yang
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

5.  Cholestasis: A Prospective Study of Perinatal Outcomes and Time to Symptom Improvement.

Authors:  Casey S Yule; Denisse S Holcomb; Alexandria C Kraus; Charles E L Brown; Donald D McIntire; David B Nelson
Journal:  Am J Perinatol       Date:  2020-09-24       Impact factor: 1.862

6.  Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial.

Authors:  Titta Joutsiniemi; Susanna Timonen; Riitta Leino; Pertti Palo; Ulla Ekblad
Journal:  Arch Gynecol Obstet       Date:  2013-08-27       Impact factor: 2.344

7.  Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus.

Authors:  Chun Zhao; Jing Dong; Tao Jiang; Zhonghua Shi; Bin Yu; Yunlong Zhu; Daozhen Chen; Junrong Xu; Ran Huo; Juncheng Dai; Yankai Xia; Shiyang Pan; Zhibin Hu; Jiahao Sha
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

8.  Trends in the development of miRNA bioinformatics tools.

Authors:  Liang Chen; Liisa Heikkinen; Changliang Wang; Yang Yang; Huiyan Sun; Garry Wong
Journal:  Brief Bioinform       Date:  2019-09-27       Impact factor: 11.622

9.  A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial.

Authors:  William M Hague; Leonie Callaway; Jennifer Chambers; Lucy Chappell; Suzette Coat; Jiska de Haan-Jebbink; Marloes Dekker; Peter Dixon; Jodie Dodd; Maria Fuller; Sanne Gordijn; Dorothy Graham; Oskari Heikinheimo; Annemarie Hennessy; Risto Kaaja; Teck Yee Khong; Laura Lampio; Jennie Louise; Angela Makris; Corey Markus; Hanns-Ulrich Marschall; Philippa Middleton; Ben W Mol; Jonathan Morris; John P Newnham; Caroline Ovadia; Michael Peek; Antonia Shand; Michael Stark; Jim Thornton; Susanna Timonen; Susan Walker; David Warrilow; Catherine Williamson
Journal:  BMC Pregnancy Childbirth       Date:  2021-01-12       Impact factor: 3.007

Review 10.  Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA.

Authors:  Tomoko Tadokoro; Asahiro Morishita; Tsutomu Masaki
Journal:  Int J Mol Sci       Date:  2021-07-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.